L2 Asset Management »

Emergent BioSolutions shares owned by L2 Asset Management

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by L2 Asset Management from 13F filings

Historical chart of L2 Asset Management investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by L2 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by L2 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $131k 11k 12.36
2025-09-30 $90k 10k 8.82
2025-06-30 $76k 12k 6.38

More positions owned by L2 Asset Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ishares Tr Eafe Value Etf (EFV)
Meta Platforms Cl A (META)
Expedia Group Com New (EXPE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for L2 Asset Management

Top funds holding Emergent BioSolutions

BlackRock
Oak Hill Advisors
Vanguard Group
State Street Corporation
American Century Companies
Dimensional Fund Advisors
Charles Schwab Investment Management
Palisade Capital Management
Geode Capital Management
Acadian Asset Management
Jain Global
LSV Asset Management
Connor, Clark & Lunn Investment Management
Prescott Group Capital Management
Marshall Wace

View all funds holding Emergent BioSolutions